345 related articles for article (PubMed ID: 24699704)
1. Stem cell transplantation for amyotrophic lateral sclerosis: therapeutic potential and perspectives on clinical translation.
Faravelli I; Riboldi G; Nizzardo M; Simone C; Zanetta C; Bresolin N; Comi GP; Corti S
Cell Mol Life Sci; 2014 Sep; 71(17):3257-68. PubMed ID: 24699704
[TBL] [Abstract][Full Text] [Related]
2. Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy.
O'Connor DM; Boulis NM
Neurosci Lett; 2012 Oct; 527(2):78-84. PubMed ID: 22579818
[TBL] [Abstract][Full Text] [Related]
3. Intraspinal stem cell transplantation for amyotrophic lateral sclerosis.
Chen KS; Sakowski SA; Feldman EL
Ann Neurol; 2016 Mar; 79(3):342-53. PubMed ID: 26696091
[TBL] [Abstract][Full Text] [Related]
4. Neural and glial progenitor transplantation as a neuroprotective strategy for Amyotrophic Lateral Sclerosis (ALS).
Haidet-Phillips AM; Maragakis NJ
Brain Res; 2015 Dec; 1628(Pt B):343-350. PubMed ID: 26187754
[TBL] [Abstract][Full Text] [Related]
5. Advances, Challenges, and Perspectives in Translational Stem Cell Therapy for Amyotrophic Lateral Sclerosis.
Abati E; Bresolin N; Comi G; Corti S
Mol Neurobiol; 2019 Oct; 56(10):6703-6715. PubMed ID: 30911936
[TBL] [Abstract][Full Text] [Related]
6. Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model.
Nizzardo M; Simone C; Rizzo F; Ruggieri M; Salani S; Riboldi G; Faravelli I; Zanetta C; Bresolin N; Comi GP; Corti S
Hum Mol Genet; 2014 Jan; 23(2):342-54. PubMed ID: 24006477
[TBL] [Abstract][Full Text] [Related]
7. Stem cells for amyotrophic lateral sclerosis modeling and therapy: myth or fact?
Coatti GC; Beccari MS; Olávio TR; Mitne-Neto M; Okamoto OK; Zatz M
Cytometry A; 2015 Mar; 87(3):197-211. PubMed ID: 25645594
[TBL] [Abstract][Full Text] [Related]
8. Intraspinal cell transplantation for targeting cervical ventral horn in amyotrophic lateral sclerosis and traumatic spinal cord injury.
Lepore AC
J Vis Exp; 2011 Sep; (55):. PubMed ID: 21946609
[TBL] [Abstract][Full Text] [Related]
9. Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS.
Lepore AC; O'Donnell J; Kim AS; Williams T; Tuteja A; Rao MS; Kelley LL; Campanelli JT; Maragakis NJ
PLoS One; 2011; 6(10):e25968. PubMed ID: 21998733
[TBL] [Abstract][Full Text] [Related]
10. Stem cell therapy in amyotrophic lateral sclerosis.
Meamar R; Nasr-Esfahani MH; Mousavi SA; Basiri K
J Clin Neurosci; 2013 Dec; 20(12):1659-63. PubMed ID: 24148693
[TBL] [Abstract][Full Text] [Related]
11. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
12. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS.
Suzuki M; McHugh J; Tork C; Shelley B; Klein SM; Aebischer P; Svendsen CN
PLoS One; 2007 Aug; 2(8):e689. PubMed ID: 17668067
[TBL] [Abstract][Full Text] [Related]
13. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.
Coatti GC; Frangini M; Valadares MC; Gomes JP; Lima NO; Cavaçana N; Assoni AF; Pelatti MV; Birbrair A; de Lima ACP; Singer JM; Rocha FMM; Da Silva GL; Mantovani MS; Macedo-Souza LI; Ferrari MFR; Zatz M
Stem Cell Rev Rep; 2017 Oct; 13(5):686-698. PubMed ID: 28710685
[TBL] [Abstract][Full Text] [Related]
14. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
15. Stem cells in amyotrophic lateral sclerosis: motor neuron protection or replacement?
Silani V; Calzarossa C; Cova L; Ticozzi N
CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):314-24. PubMed ID: 20406179
[TBL] [Abstract][Full Text] [Related]
16. Advancing Stem Cell Therapy for Repair of Damaged Lung Microvasculature in Amyotrophic Lateral Sclerosis.
Garbuzova-Davis S; Shell R; Mustafa H; Hailu S; Willing AE; Sanberg PR; Borlongan CV
Cell Transplant; 2020; 29():963689720913494. PubMed ID: 32207340
[TBL] [Abstract][Full Text] [Related]
17. Transplantation of clinical-grade human neural stem cells reduces neuroinflammation, prolongs survival and delays disease progression in the SOD1 rats.
Zalfa C; Rota Nodari L; Vacchi E; Gelati M; Profico D; Boido M; Binda E; De Filippis L; Copetti M; Garlatti V; Daniele P; Rosati J; De Luca A; Pinos F; Cajola L; Visioli A; Mazzini L; Vercelli A; Svelto M; Vescovi AL; Ferrari D
Cell Death Dis; 2019 Apr; 10(5):345. PubMed ID: 31024007
[TBL] [Abstract][Full Text] [Related]
18. Concise review: Stem cell therapies for amyotrophic lateral sclerosis: recent advances and prospects for the future.
Lunn JS; Sakowski SA; Feldman EL
Stem Cells; 2014 May; 32(5):1099-109. PubMed ID: 24448926
[TBL] [Abstract][Full Text] [Related]
19. Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model.
Marconi S; Bonaconsa M; Scambi I; Squintani GM; Rui W; Turano E; Ungaro D; D'Agostino S; Barbieri F; Angiari S; Farinazzo A; Constantin G; Del Carro U; Bonetti B; Mariotti R
Neuroscience; 2013 Sep; 248():333-43. PubMed ID: 23727509
[TBL] [Abstract][Full Text] [Related]
20. Neural induction with neurogenin 1 enhances the therapeutic potential of mesenchymal stem cells in an amyotrophic lateral sclerosis mouse model.
Chan-Il C; Young-Don L; Heejaung K; Kim SH; Suh-Kim H; Kim SS
Cell Transplant; 2013; 22(5):855-70. PubMed ID: 22472631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]